Company: BIVIW
Filing Date: 2025-07-11
Form Type: S-1/A
Source: 0001520138-25-000205
Chunk: 18

Company: BIOVIE INC.
Filing Date: 2025-07-11
Form: S-1/A
Chunk 18
---
 | Our stock price is and may continue to be volatile and you may not be able to resell our Common Stock 
 at or above the price you paid.                                                                       |

| · | Nasdaq may seek to delist our Common Stock if it concludes this offering does not qualify as a public 
 offering as defined under Nasdaq’s stockholder approval rule.                                         |

| · | We do not intend to pay dividends on our Common Stock, so any returns will be limited to the value of 
 our Common Stock.                                                                                     |

| · | You may experience future dilution as a result of future equity offerings or if we issue shares subject 
 to options, warrants, stock awards or other arrangements.                                               |

| · | Limited trading market for our Common Stock could make it difficult to liquidate an investment. |

| · | There is no established public trading market for the Pre-funded Warrants or Warrants being offered in 
 this offering, and we do not expect a market to develop for the Pre-funded Warrants or Warrants.       |

| · | The Pre-funded Warrants or Warrants are speculative in nature. |

| · | The Reverse Stock Split has caused and could further cause our stock price to decline relative       
 to its value before the Reverse Stock Split and decrease the liquidity of shares of our Common Stock |

| · | Any failure to maintain effective internal control over financial reporting could harm us. |

| · | The lack of public company experience of our management team could negatively affect our business. |

| · | Investors may be less attracted to our Common Stock because we are as a smaller reporting company. |

| · | We are subject to the periodic reporting requirements of the Exchange Act, which require us to incur audit                                
 fees and legal fees in connection with the preparation of such reports. These additional costs will negatively affect our ability to earn 
 a profit.                                                                                                                                 |

| · | Because we do not intend to pay any cash dividends on our Common Stock, our stockholders will not be able 
 to receive a return on their shares unless they sell them.                                                |

| · | We are authorized to issue “blank check” preferred stock without stockholder approval, which 
 could adversely impact the rights of holders of our securities.                              |

| · | Provisions in our Articles of Incorporation, our Bylaws, and Nevada law might discourage, delay or prevent                     
 a change in control of our company or changes in our management and, therefore, depress the trading price of our Common Stock. |

Corporate Information Our principal executive office is located